Blackstone Valuation
Is BX * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BX * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BX * (MX$2102.06) is trading above our estimate of fair value (MX$2060.67)
Significantly Below Fair Value: BX * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BX *?
Other financial metrics that can be useful for relative valuation.
What is BX *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$139.41b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | n/a |
Enterprise Value/EBITDA | n/a |
PEG Ratio | 1.5x |
Price to Earnings Ratio vs Peers
How does BX *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 32.2x | ||
GPROFUT * Grupo Profuturo. de | 10.1x | n/a | Mex$28.9b |
GBM O Corporativo GBM. de | 77.4x | n/a | Mex$22.0b |
KKR KKR | 22.4x | 9.4% | US$82.4b |
BLK BlackRock | 19x | 7.0% | US$112.3b |
BX * Blackstone | 39.1x | 26.1% | Mex$139.4b |
Price-To-Earnings vs Peers: BX * is expensive based on its Price-To-Earnings Ratio (39.1x) compared to the peer average (32.2x).
Price to Earnings Ratio vs Industry
How does BX *'s PE Ratio compare vs other companies in the South American Capital Markets Industry?
Price-To-Earnings vs Industry: BX * is expensive based on its Price-To-Earnings Ratio (39.1x) compared to the South American Capital Markets industry average (9.5x).
Price to Earnings Ratio vs Fair Ratio
What is BX *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 39.1x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate BX *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$2,102.06 | Mex$2,131.45 +1.4% | 9.3% | Mex$2,442.79 | Mex$1,696.38 | n/a | 17 |
Apr ’25 | Mex$2,162.46 | Mex$2,126.34 -1.7% | 11.4% | Mex$2,494.73 | Mex$1,596.62 | n/a | 20 |
Mar ’25 | Mex$2,169.58 | Mex$2,173.28 +0.2% | 11.5% | Mex$2,552.79 | Mex$1,633.79 | n/a | 20 |
Feb ’25 | Mex$2,226.99 | Mex$2,164.71 -2.8% | 12.0% | Mex$2,573.81 | Mex$1,647.24 | n/a | 19 |
Jan ’25 | Mex$2,255.48 | Mex$1,918.59 -14.9% | 13.1% | Mex$2,560.40 | Mex$1,519.17 | n/a | 20 |
Dec ’24 | Mex$1,955.25 | Mex$1,867.55 -4.5% | 7.5% | Mex$2,083.63 | Mex$1,545.36 | n/a | 18 |
Nov ’24 | Mex$1,662.17 | Mex$1,928.42 +16.0% | 7.6% | Mex$2,179.69 | Mex$1,616.60 | n/a | 18 |
Oct ’24 | Mex$1,914.03 | Mex$1,994.31 +4.2% | 5.8% | Mex$2,210.44 | Mex$1,715.30 | n/a | 18 |
Sep ’24 | Mex$1,759.50 | Mex$1,927.13 +9.5% | 6.2% | Mex$2,141.25 | Mex$1,661.61 | n/a | 18 |
Aug ’24 | Mex$1,784.61 | Mex$1,890.42 +5.9% | 6.2% | Mex$2,103.59 | Mex$1,632.38 | n/a | 18 |
Jul ’24 | Mex$1,600.00 | Mex$1,731.37 +8.2% | 6.7% | Mex$1,963.80 | Mex$1,451.50 | n/a | 18 |
Jun ’24 | Mex$1,542.44 | Mex$1,788.93 +16.0% | 6.6% | Mex$2,026.86 | Mex$1,498.12 | n/a | 18 |
May ’24 | Mex$1,584.03 | Mex$1,799.49 +13.6% | 9.7% | Mex$2,067.69 | Mex$1,267.58 | Mex$2,102.06 | 18 |
Apr ’24 | Mex$1,564.11 | Mex$1,861.24 +19.0% | 11.4% | Mex$2,096.04 | Mex$1,257.62 | Mex$2,162.46 | 17 |
Mar ’24 | Mex$1,632.00 | Mex$1,921.72 +17.8% | 11.3% | Mex$2,160.41 | Mex$1,296.25 | Mex$2,169.58 | 17 |
Feb ’24 | Mex$1,795.90 | Mex$1,931.57 +7.6% | 11.2% | Mex$2,158.46 | Mex$1,304.46 | Mex$2,226.99 | 17 |
Jan ’24 | Mex$1,442.11 | Mex$1,938.08 +34.4% | 13.1% | Mex$2,259.15 | Mex$1,326.02 | Mex$2,255.48 | 16 |
Dec ’23 | Mex$1,638.33 | Mex$2,020.05 +23.3% | 12.9% | Mex$2,485.47 | Mex$1,310.69 | Mex$1,955.25 | 16 |
Nov ’23 | Mex$1,840.00 | Mex$2,097.00 +14.0% | 10.5% | Mex$2,531.10 | Mex$1,704.01 | Mex$1,662.17 | 16 |
Oct ’23 | Mex$1,693.00 | Mex$2,436.76 +43.9% | 11.3% | Mex$3,081.19 | Mex$2,033.99 | Mex$1,914.03 | 14 |
Sep ’23 | Mex$1,888.41 | Mex$2,460.07 +30.3% | 10.3% | Mex$3,081.56 | Mex$2,054.37 | Mex$1,759.50 | 14 |
Aug ’23 | Mex$1,955.22 | Mex$2,472.75 +26.5% | 10.2% | Mex$2,996.46 | Mex$2,079.18 | Mex$1,784.61 | 13 |
Jul ’23 | Mex$1,777.95 | Mex$2,855.22 +60.6% | 16.7% | Mex$3,623.22 | Mex$2,073.29 | Mex$1,600.00 | 13 |
Jun ’23 | Mex$2,289.67 | Mex$2,931.19 +28.0% | 12.5% | Mex$3,585.46 | Mex$2,430.14 | Mex$1,542.44 | 13 |
May ’23 | Mex$2,170.36 | Mex$2,965.33 +36.6% | 13.2% | Mex$3,711.03 | Mex$2,467.23 | Mex$1,584.03 | 14 |
Analyst Forecast: Target price is less than 20% higher than the current share price.